1. M. Benetkiewicz, A. Idbaih, P. Y. Cousin, B. Boisselier, Y. Marie, E. Criniere, K. Hoang-Xuan, J. Y. Delattre, M. Sanson, and O. Delattre. NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas. PLoS ONE, 4(1):e4107, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Base Sequence, *Brain Neoplasms/genetics/metabolism, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, *Gene Rearrangement, Humans, Molecular Sequence Data, *Mutation, *Oligodendroglioma/genetics/metabolism, Oligonucleotide Array Sequence Analysis, Receptor, Notch2/*genetics/metabolism, *Translocation, Genetic.



2. B. Boisselier, Y. Marie, S. El Hallani, G. Kaloshi, A. Iershov, V. Kavsan, D. Psimaras, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis. J Neurooncol, 94(2):169-72, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW]



3. S. El Hallani, B. Boisselier, Y. Marie, S. Paris, A. Idbaih, C. Carpentier, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 mutations but no CHEK2 *1100DelC variant in familial gliomas. Cancer Genet Cytogenet, 188(2):126-8, 2009. Note: LetterUnited States. [WWW] Keyword(s): Family, Female, Genetic Variation, Germ-Line Mutation, Glioma/*genetics, Humans, Male, *Mutation, Protein-Serine-Threonine Kinases/*genetics, *Sequence Deletion, Tumor Suppressor Protein p53/*genetics.



4. S. El Hallani, F. Ducray, A. Idbaih, Y. Marie, B. Boisselier, C. Colin, F. Laigle-Donadey, M. Rodero, O. Chinot, J. Thillet, K. Hoang-Xuan, J. Y. Delattre, and M. Sanson. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology, 72(4):332-6, 2009. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Age of Onset, Aged, Aged, 80 and over, Codon/blood/*genetics, Female, Follow-Up Studies, Gene Frequency/genetics, Genetic Variation/genetics, Glioblastoma/blood/epidemiology/*genetics, Humans, Male, Middle Aged, Mutation/genetics, Polymorphism, Single Nucleotide/*genetics, Tumor Suppressor Protein p53/blood/*genetics, Young Adult.



5. A. Idbaih, J. Aimard, B. Boisselier, Y. Marie, S. Paris, E. Criniere, R. Carvalho Silva, F. Laigle-Donadey, A. Rousseau, K. Mokhtari, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma. Neuropathol Appl Neurobiol, 35(2):208-13, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Age of Onset, Brain Neoplasms/chemistry/*genetics, DNA Mutational Analysis, Female, Gene Expression, Glioblastoma/chemistry/*genetics, Humans, Male, Mutation, Missense, Protein Structure, Quaternary, Protein Structure, Tertiary, Receptor, Epidermal Growth Factor/chemistry/*genetics, Sex Characteristics.



6. M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. El Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, and J. Y. Delattre. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 27(25):4150-4, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Brain Neoplasms/enzymology/*genetics/mortality/pathology/therapy, Codon, DNA Methylation, DNA Modification Methylases/genetics, DNA Repair Enzymes/genetics, Disease-Free Survival, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glioma/enzymology/*genetics/mortality/pathology/therapy, Humans, Isocitrate Dehydrogenase/*genetics, Kaplan-Meiers Estimate, Male, Middle Aged, *Mutation, Neoplasm Staging, Promoter Regions, Genetic, Proportional Hazards Models, Risk Assessment, Time Factors, Treatment Outcome, Tumor Markers, Biological/*genetics, Tumor Suppressor Proteins/genetics, Young Adult.



7. S. Shete, F. J. Hosking, L. B. Robertson, S. E. Dobbins, M. Sanson, B. Malmer, M. Simon, Y. Marie, B. Boisselier, J. Y. Delattre, K. Hoang-Xuan, S. El Hallani, A. Idbaih, D. Zelenika, U. Andersson, R. Henriksson, A. T. Bergenheim, M. Feychting, S. Lonn, A. Ahlbom, J. Schramm, M. Linnebank, K. Hemminki, R. Kumar, S. J. Hepworth, A. Price, G. Armstrong, Y. Liu, X. Gu, R. Yu, C. Lau, M. Schoemaker, K. Muir, A. Swerdlow, M. Lathrop, M. Bondy, and R. S. Houlston. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet, 41(8):899-904, 2009. Note: 5R01 CA070917/CA/NCI NIH HHS/United States5R01 CA119215/CA/NCI NIH HHS/United StatesC1298/A8362/Cancer Research UK/United KingdomR01 CA119215/CA/NCI NIH HHS/United StatesWellcome Trust/United KingdomJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Alleles, *Genetic Predisposition to Disease, *Genome-Wide Association Study, Glioma/*genetics, Humans, Linkage Disequilibrium/genetics, Polymorphism, Single Nucleotide/genetics, Reproducibility of Results.



8. A. Idbaih, B. Boisselier, Y. Marie, M. Sanson, S. El Hallani, E. Criniere, M. Fourtassi, S. Paris, C. Carpentier, A. Rousseau, K. Mokhtari, C. Combadiere, F. Laigle-Donadey, K. Hoang-Xuan, and J. Y. Delattre. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Res, 1198:16-20, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adolescent, Adult, Age Factors, Aged, Brain Neoplasms/*genetics/metabolism/physiopathology, Chromosomes, Human, Pair 1/genetics, DNA Mutational Analysis, Female, Genetic Predisposition to Disease/*genetics, Genetic Screening, Genotype, Humans, Male, Middle Aged, Oligodendroglioma/*genetics/metabolism/physiopathology, Phenotype, Polymorphism, Single Nucleotide/*genetics, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Retrospective Studies, Survival Rate, Tumor Suppressor Protein p53/*genetics.



9. A. Idbaih, R. Carvalho Silva, E. Criniere, Y. Marie, C. Carpentier, B. Boisselier, S. Taillibert, A. Rousseau, K. Mokhtari, F. Ducray, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Genomic changes in progression of low-grade gliomas. J Neurooncol, 90(2):133-40, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Chromosome Deletion, Chromosomes, Disease Progression, Female, Genome/*genetics, Glioma/*genetics/*metabolism, Humans, Male, Microsatellite Repeats, Middle Aged, Nucleic Acid Hybridization/methods.



10. A. Idbaih, E. Criniere, Y. Marie, A. Rousseau, K. Mokhtari, M. Kujas, Y. El Houfi, C. Carpentier, S. Paris, B. Boisselier, F. Laigle-Donadey, J. Thillet, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro Oncol, 10(4):540-7, 2008. Note: Journal ArticleUnited States. [WWW]



11. A. Idbaih, S. Paris, B. Boisselier, Y. Marie, M. Sanson, J. Thillet, K. Hoang-Xuan, and J. Y. Delattre. Mutational analysis of Rac2 in gliomas. J Neurooncol, 87(3):365-6, 2008. Note: LetterResearch Support, Non-U.S. Gov'tNetherlands. [WWW]



12. S. El Hallani, Y. Marie, A. Idbaih, M. Rodero, B. Boisselier, F. Laigle-Donadey, F. Ducray, J. Y. Delattre, and M. Sanson. No association of MDM2 SNP309 with risk of glioblastoma and prognosis. J Neurooncol, 85(3):241-4, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Brain Neoplasms/*genetics/mortality/pathology, Case-Control Studies, Female, Gene Expression Regulation, Neoplastic/genetics, Genetic Predisposition to Disease, Glioblastoma/*genetics/mortality/pathology, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Prognosis, Proto-Oncogene Proteins c-mdm2/*genetics, Reference Values, Risk Factors, Survival Analysis, Tumor Markers, Biological/*genetics.



13. A. Idbaih, B. Boisselier, M. Sanson, E. Criniere, S. Liva, Y. Marie, C. Carpentier, S. Paris, F. Laigle-Donadey, K. Mokhtari, M. Kujas, K. Hoang-Xuan, O. Delattre, and J. Y. Delattre. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas. Cancer Genet Cytogenet, 176(2):121-126, 2007. Note: Journal article. [WWW]

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html